News Line

    Go to Home Back
Email this to a friend
Printable version
Friday, February 20, 2015 - 05.37 GMT

Genetic Screening in Sri Lanka for first time


Credence Genomics, the country's first and only commercial Biotechnology venture, equipped with Next Generation Sequencing technology is launched today (Feb. 20) at the Sri Lanka Foundation Institute SLFI.

With the establishment of this venture, Sri Lanka will be able to analyze DNA samples to detect the presence of a gene or genes associated with an inherited disorder.

The farsighted team behind this pioneering venture - Dr. Vaz Santosh Gnanam, Raj K. Omprasadham, Ananda Atukorale and Malaka Talwatta - has succeeded where few have dared to venture and are the first such entity in Sri Lanka, and in fact are amongst a handful in the world at the forefront of this field.

In Sri Lanka for the launch is Dr. Michael Paumen, Senior Director of Medical Sciences of Asia Pacific and Japan, Life Sciences Solutions, Thermo Fisher Scientific Inc. who are the world leaders in serving science, with revenues of $17 billion and around 50,000 employees in 50 countries.





Contact Information:: Send mail to with questions or comments about this web site.
Last modified: February 20, 2015.

Copyright 2008 Policy Research & Information Unit of the Presidential Secretariat of Sri Lanka. All Rights Reserved.